Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)
Authors
Keywords
-
Journal
Rheumatology and Therapy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-04-18
DOI
10.1007/s40744-023-00546-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia
- (2022) Earl Sands et al. Nature Communications
- The effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review
- (2021) Robert T. Keenan et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- 2020 American College of Rheumatology Guideline for the Management of Gout
- (2020) John D. FitzGerald et al. Arthritis & Rheumatology
- Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
- (2020) Takashi Kei Kishimoto Frontiers in Immunology
- Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis
- (2020) Valeria Valerio et al. CLINICAL RHEUMATOLOGY
- Pegloticase in combination with methotrexate in patients with uncontrolled gout: A multicenter, open-label study (MIRROR)
- (2020) John K. Botson et al. JOURNAL OF RHEUMATOLOGY
- Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
- (2020) Megan Francis-Sedlak et al. Rheumatology and Therapy
- Safety and tolerability of available urate-lowering drugs: a critical review
- (2019) Larysa Strilchuk et al. Expert Opinion On Drug Safety
- Stomatitis And Everolimus: A Review Of Current Literature On 8,201 Patients
- (2019) Claudia Arena et al. OncoTargets and Therapy
- Improving adherence to gout therapy: an expert review
- (2018) Fernando Perez-Ruiz et al. Therapeutics and Clinical Risk Management
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2016 updated EULAR evidence-based recommendations for the management of gout
- (2016) P Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles
- (2016) Takashi K. Kishimoto et al. Nature Nanotechnology
- Medication Adherence in Gout: A Systematic Review
- (2014) Mary A. De Vera et al. ARTHRITIS CARE & RESEARCH
- Pegloticase: A Novel Agent for Treatment-Refractory Gout
- (2012) Jennifer A Shannon et al. ANNALS OF PHARMACOTHERAPY
- Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
- (2012) Ricardo P Garay et al. Expert Opinion on Drug Delivery
- The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue
- (2012) Maria J. Pereira et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
- (2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Common toxicities of mammalian target of rapamycin inhibitors
- (2011) Scott A. Soefje et al. Targeted Oncology
- Chronic gout: epidemiology, disease progression, treatment and disease burden
- (2010) Richard A. Brook et al. CURRENT MEDICAL RESEARCH AND OPINION
- Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide
- (2009) J R Curtis et al. ANNALS OF THE RHEUMATIC DISEASES
- Refractory gout: what is it and what to do about it?
- (2009) Edward Fels et al. CURRENT OPINION IN RHEUMATOLOGY
- Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: Results of a phase II randomized study
- (2008) John S. Sundy et al. ARTHRITIS AND RHEUMATISM
- Treatment-failure gout: A moving target
- (2008) N. Lawrence Edwards ARTHRITIS AND RHEUMATISM
- The Impact of PEGylation on Biological Therapies
- (2008) Francesco M Veronese et al. BIODRUGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now